K. Pudi

Randomized dose-finding study of batefenterol via dry powder inhaler in patients with COPD

E. Kerwin, E. Bateman, C. Crim, 2019, International journal of chronic obstructive pulmonary disease.

Efficacy and safety of ipratropium bromide/albuterol delivered via Respimat inhaler versus MDI.

R. Zuwallack, E. Bateman, M. De Salvo, 2010, Respiratory medicine.

Efficacy and safety of ipratropium bromide/ albuterol delivered via Respimatinhaler

R. Zuwallack, P. Sachs, F. Fakih, 2010 .

Effect of once-daily fluticasone furoate/vilanterol on 24-hour pulmonary function in patients with chronic obstructive pulmonary disease: a randomized, three-way, incomplete block, crossover study.

C. Crim, J. Boscia, S. Siederer, 2012, Clinical therapeutics.

Improvements in Lung Function with Nebulized Revefenacin in the Treatment of Patients with Moderate to Very Severe COPD: Results from Two Replicate Phase III Clinical Trials.

G. Feldman, E. Moran, G. Ferguson, 2019, Chronic obstructive pulmonary diseases.

A 28-day, randomized, double-blind, placebo-controlled, parallel group study of nebulized revefenacin in patients with chronic obstructive pulmonary disease

E. Kerwin, E. Moran, C. Barnes, 2017, Respiratory Research.

24-h bronchodilation and inspiratory capacity improvements with glycopyrrolate/formoterol fumarate via co-suspension delivery technology in COPD

G. Feldman, C. Reisner, G. Gottschlich, 2017, Respiratory Research.

An Open-Label Study Evaluating the Performance of the Dose Indicator in a Metered Dose Inhaler Delivering Glycopyrrolate and Formoterol Fumarate in Patients with Moderate-to-Very Severe Chronic Obstructive Pulmonary Disease

G. Feldman, C. Reisner, P. Mack, 2019, Journal of aerosol medicine and pulmonary drug delivery.